ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,978 | +29640.4% | 143,299 | +1418.0% | 0.04% | – |
| Q2 2023 | $47 | 0.0% | 9,440 | 0.0% | 0.00% | – |
| Q1 2023 | $47 | -20.3% | 9,440 | 0.0% | 0.00% | – |
| Q4 2022 | $59 | -99.9% | 9,440 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $102,000 | -5.6% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $108,000 | +25.6% | 9,440 | 0.0% | 0.00% | – |
| Q1 2022 | $86,000 | -39.0% | 9,440 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $141,000 | -42.0% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $243,000 | -1.2% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $246,000 | -26.1% | 9,440 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $333,000 | +39.9% | 9,440 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $238,000 | -33.1% | 9,440 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $356,000 | -11.9% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $404,000 | – | 9,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |